Psychotherapy in Major Depressive Breast Cancer Patients
Not Applicable
- Conditions
- eoplasms.Malignant neoplasm of breast
- Registration Number
- IRCT2015063022991N1
- Lead Sponsor
- Babol University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
Breast cancer in the stage III or more; HADS score equals or more than 11 which can be due to symptomatic major depression; informed consent of the patient for participation in the study
Exclusion criteria: severe psychiatric disorders such as psychosis or substance abuse; severe neurologic diseases; mental retardation; endocrine disorders
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Quality of life. Timepoint: 3th, 6th and 12th weeks. Method of measurement: WHO Quality of Life Questionnaire (WHO-QOL BREF).;Severity of depression in the patient. Timepoint: 3th, 6th and 12th weeks. Method of measurement: Hospital Anxiety and Depression Scale (HADS).
- Secondary Outcome Measures
Name Time Method The number of suicidal attempts. Timepoint: 3th, 6th and 12th weeks. Method of measurement: self-report questionnaire.